The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Clinical actionability of molecular targets in endometrial cancer
Open accessAbstract
Endometrial cancer accounts for ~76,000 deaths among women each year worldwide. Disease mortality and the increasing number of new diagnoses make endometrial cancer an important consideration in women's health, particularly in industrialized countries, where the incidence of this tumour type is highest. Most endometrial cancers are carcinomas, with the remainder being sarcomas. Endometrial carcinomas can be classified into several histological subtypes, including endometrioid, serous and clear cell carcinomas. Histological subtyping is currently used routinely to guide prognosis and treatment decisions for endometrial cancer patients, while ongoing studies are evaluating the potential clinical utility of molecular subtyping. In this Review, we summarize the overarching molecular features of endometrial cancers and highlight recent studies assessing the potential clinical utility of specific molecular features for early detection, disease risk stratification and directing targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the combined presence of PTEN and PIK3CA or PIK3R1 mutations are frequently observed suggesting that both loss of tumor suppressor and activation of oncogenes is required during tumor progression53.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [53]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., Srinivasan, P., Gao, J., Chakravarty, D., Devlin, S. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4333 · Cited by 3,380
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
Behan, F. M., Iorio, F., Picco, G., Gonçalves, E., Beaver, C. M., Migliardi, G., Santos, R., Rao, Y., Sassi, F., Pinnelli, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1103-9 · Cited by 1,338
Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer
Talhouk, A., McConechy, M. K., Leung, S. C. Y., Yang, W., Lum, A. M., Senz, J., Boyd, N., Pike, J. A., Anglesio, M. S., Kwon, J. S., et al. (2017) · Cancer · doi:10.1002/cncr.30496 · Cited by 1,007
A clinically applicable molecular-based classification for endometrial cancers
Talhouk, A., McConechy, M. K., Leung, S. C. Y., Li-Chang, H. H., Kwon, J. S., Melnyk, N., Yang, W., Senz, J., Boyd, N., Karnezis, A. N., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.190 · Cited by 989
Stelloo, E., Nout, R. A., Osse, E. M., Jurgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C. H. W., van der Steen‐Banasik, E. M., Nijman, H. W., Putter, H., Bosse, T., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2878 · Cited by 856
Cited by
Sorted by citations
Items 301–400 of 411
Effects of CLDN9 on Proliferation of Uterine Corpus Endometrioid Carcinoma Cells
Zhang, J., Kuang, P., Wan, F., Zhang, Y., Zhang, W., & Zhang, X. (2023) · International Conference on Bioinformatics and Biomedical Technology (ICBBT) · doi:10.1145/3608164.3608183 · Cited by 2
Tao, W., Yan, Q., Zhou, Y., Wang, Y., Liu, Z., & Xu, Z. (2021) · Science Progress · doi:10.1177/00368504211004028 · Cited by 2
Arend, R. C., Scalise, C. B., Dholakia, J., Kamal, M. Z., Thigpen, H. B., Crossman, D. K., Huh, W. K., & Leath, C. A. (2021) · Cancer Medicine · doi:10.1002/cam4.4247 · Cited by 2
Research Progress on Molecular Typing of Endometrial Carcinoma
李, 莹. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.132360 · Cited by 1
Matsuura, M., Takane, K., Yamaguchi, K., Ikenoue, T., Hatakeyama, S., Kurokawa, S., Tamate, M., Akimoto, T., Iwasaki, M., Sugita, S., et al. (2023) · BJC Reports · doi:10.1038/s44276-023-00020-y · Cited by 1
Clinical analysis of molecular typing of 146 cases of endometrial carcinoma
Zhang, B., Zhou, D., Zhang, S., Yan, J., Meng, Q., & Lv, Q. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2024.1482817 · Cited by 1
Yang, T., & Liu, B. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-17157-4 · Cited by 1
Li, Q., Muheteer, N., Ayoufu, G., Abulimiti, X., Aini, A., Han, B.-J., Fulati, R., Ainiwaer, M., & Abudourousuli, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-07379-7 · Cited by 1
Guo, C., Zheng, J., Lin, X., Ye, X. Z., Jiang, X., & Sun, Y. (2025) · Molecular Carcinogenesis · doi:10.1002/mc.70041 · Cited by 1
EIF1AX Nucleolar Condensates Enhance Susceptibilities for the Management of Endometrial Cancer
Lv, C., Lin, Z., Sun, J., Ye, Y., Wu, Q., Cai, L., Liu, D., Sun, P., & Wang, S. (2025) · Advanced Science · doi:10.1002/advs.202504238 · Cited by 1
Rethinking estrogen receptor β in EAOC: a synergistic modulator in a genomically informed landscape
Luo, L., Dai, W., Cao, N., & Ye, M. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-01990-6 · Cited by 1
Lu, S., Xu, J., Sun, X., Yuan, J., Cheng, J., & Qin, J. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04230-x · Cited by 1
COX7A1-mediated mitochondrial dysfunction can induce ferroptosis in endometrial cancer cells
Wu, Q., Bai, S., Song, L., Han, L., & Wang, P. (2026) · PLoS ONE · doi:10.1371/journal.pone.0342333 · Cited by 1
Jiang, R., Lin, X., Zheng, J., Xie, N., Li, Y., Lin, F., Wang, S., Zhang, R., & Sun, Y. (2026) · BMC Cancer · doi:10.1186/s12885-026-15858-x · Cited by 1
The impact of endocrine-disrupting chemicals on uterine diseases
Hayashi, K., & MacLean, J. A. (2026) · Biology of Reproduction · doi:10.1093/biolre/ioag082 · Cited by 1
Lepold, M. L., & Soares, A. C. P. (2022) · Hawking eBooks · doi:10.29327/561995.1-5 · Cited by 1
Association Between Gestational Diabetes History with Endometrial Hyperplasia and Cancer
Bouzari, Z., Mohammadi, T., Ranaei, M., Hajian‐Tilaki, K., & Ghanbarpour, A. (2022) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.30699/jogcr.7.5.414 · Cited by 1
He, Y., Cao, N., Tian, Y., Wang, X., Xiao, Q., Tang, X., Huang, J., Zhu, T., Hu, C., Zhang, Y., et al. (2023) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2023453 · Cited by 1
Chang, F., Liu, H., Wan, J., Gao, Y., Wang, Z., Zhang, L., & Feng, Q. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10443-4 · Cited by 1
Wang, H., Xiao, Y., Cai, Y., Zhou, Y., Chen, L., Guo, J., Shi, X., & Liang, Z. (2024) · International Journal of Women s Health · doi:10.2147/ijwh.s465255 · Cited by 1
IL-4, IL-7, IL-9, NT, NRP1 May Be Useful Markers in the Diagnosis of Endometrial Cancer
Kozłowski, M., Borzyszkowska, D., Lerch, N., Turoń-Skrzypińska, A., Tkacz, M., Lubikowski, J., Tarnowski, M., Rotter, I., & Cymbaluk‐Płoska, A. (2024) · Biomolecules · doi:10.3390/biom14091095 · Cited by 1
Wu, Q., Feng, L., Zhang, Y., Li, S., & Xiang, C. (2025) · Discover Oncology · doi:10.1007/s12672-025-01850-7 · Cited by 1
Screening tests for endometrial cancer in the general population
Njoku, K., O’Flynn, H., Jones, E. R., Ramchander, N. C., White, H., Macey, R., & Crosbie, E. J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013859 · Cited by 1
Silva, L. M., & da Rocha, J. E. S. (2022) · Hawking eBooks · doi:10.29327/561995.1-14 · Cited by 1
Animal Models of Gynecological Cancers
Venkata, P. P., Medina, D., Nirzhor, S. S. R., Sittadjody, S., Kumaran, R., Ramachandran, I., & Subbarayalu, P. (2022) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-1282-5_18-1 · Cited by 1
Aberrant claudin-6–adhesion signal promotes endometrial cancer progression via estrogen receptor αPreprint
Kojima, M., Sugimoto, K., Tanaka, M., Endo, Y., Ichikawa‐Tomikawa, N., Kashiwagi, K., Kato, H., Honda, T., Furukawa, S., Nishiyama, H., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.15.097659 · Cited by 1
Endometrial cancer at recurrence: To re-sequence or not to re-sequence
Fuh, K. C., & Manning‐Geist, B. L. (2024) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2024.101414 · Cited by 1
Guo, C., Tang, Y., Zhang, Y., & Li, G. (2020) · Research Square · doi:10.21203/rs.3.rs-126793/v1
Overexpression of LINC00936 Inhibits the Proliferation and Invasion of Endometrial Carcinoma Cells
Sun, H., & Li, P. (2022) · Journal of Oncology · doi:10.1155/2022/2223954
Oliveira, O. D. A. R., Cardoso, M. A. B., & Martins, J. A. M. (2022) · Hawking eBooks · doi:10.29327/561995.1-13
INFECÇÕES SEXUALMENTE TRANSMISSÍVEIS
Gonçalves, M. A. C., Maria, A. N. C., de Lima, B. F., Lara, R. D. A., Lepold, M. L., & Lessa, A. B. M. (2022) · Hawking eBooks · doi:10.29327/561995.1-10
DOENÇA INFLAMATÓRIA PELVICA E DOR PELVICA CRÔNICA
Barbosa, I. R. V. D. M., da Silva, L. V. A., Cunha, M. C. D. S. L., & Soares, A. C. P. (2022) · Hawking eBooks · doi:10.29327/561995.1-12
VULVOVAGINITES, CERVICITES E URETRITES
Lessa, A. B. M., & Bezerra, C. D. M. (2022) · Hawking eBooks · doi:10.29327/561995.1-9
Gonçalves, M. A. C., & Chaves, J. H. B. (2022) · Hawking eBooks · doi:10.29327/561995.1-17
dos Santos, L. D. R., Pacheco, M. G. D. A., Barreto, H., & Cavalcanti, M. G. (2022) · Hawking eBooks · doi:10.29327/561995.1-15
ENDOMETRIOSE, INFERTILIDADE CONJUGAL
Calfa, A. N., da Silva, A. P., & Albuquerque, F. C. (2022) · Hawking eBooks · doi:10.29327/561995.1-11
Souza, A. K. R., Machado, M. E. M. B., Rocha, T. M. D. C., & da Silva, M. A. E. (2022) · Hawking eBooks · doi:10.29327/561995.1-2
de Matos, M. G. B., do Nascimento, R. O., Lisboa, R. S., & Soares, A. C. P. (2022) · Hawking eBooks · doi:10.29327/561995.1-8
Meixner, E. (2022) · Journal of Oncology Research and Therapy · doi:10.29011/2574-710x.10144
Molecular Classification of Endometrial Cancer of Chinese PopulationPreprint
Kang, N., Zhang, X., Wang, Z., Dai, Y., Chen, R., Qu, L., Lu, S., Kong, F., Zhu, C., Gai, F., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2020833/v1
Animal Models of Gynecological Cancers
Venkata, P. P., Medina, D., Nirzhor, S. S. R., Sittadjody, S., Kumaran, R., Ramachandran, I., & Subbarayalu, P. (2023) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-3824-5_18
Study on biomarkers in endometrial cancer using transcriptome data: A machine learning approach
Sinnarasan, V. S. P., Paul, D., Das, R., Ampasala, D. R., & Venkatesan, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15280-1.00019-4
Kuok, C.-F., Chenyu, L., Chiian, K., Manin, L., Lirong, M., & Fong, P. (2022) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v6i5.16
Robert, J. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77967-1.00030-9
(2023) · European Journal of Gynaecological Oncology · doi:10.22514/ejgo.2023.060
An 11-GRG Predicting Model for UCEC PrognosisPreprint
Su, H., & Qiao, Z. (2023) · Research Square · doi:10.21203/rs.3.rs-3235391/v1
Lin, H., Fan, Y., Zhi, Z., Pang, L., & Sun, D. (2022) · Research Square · doi:10.21203/rs.3.rs-1438332/v1
Zhou, Q., & Zhou, H. (2023) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.spl.793
Evaluation of the genetic diversity of KIR genes in patients with endometrial cancer
Shiravani, Z., Mirshekari, K., Larki, M. H., Shafiee, N., Haghshenas, M. R., Ghaderi, A. A., & Fattahi, M. J. (2024) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2024.104217
Unveiling Residual Diseases of Endometrial Precancer/Cancer After Progestin Therapy
Zheng, W., Fadare, O., & Quick, C. M. (2024) · Springer eBooks · doi:10.1007/978-981-19-7696-4_57-1
Zhang, J., Wang, Z., Zhao, R., An, L., Zhou, X., Zhao, Y., & Wang, H. (2020) · Figshare · doi:10.6084/m9.figshare.13153007
Zhang, J., Wang, Z., Zhao, R., An, L., Zhou, X., Zhao, Y., & Wang, H. (2020) · Figshare · doi:10.6084/m9.figshare.13153013
Additional file 2 of Genomic profile of Chinese patients with endometrial carcinoma
Li, J., Li, X., Quan, C., Li, X., Wan, C., & Wu, X. (2023) · Figshare · doi:10.6084/m9.figshare.24172104
Zhang, J., Wang, Z., Zhao, R., An, L., Zhou, X., Zhao, Y., & Wang, H. (2020) · Figshare · doi:10.6084/m9.figshare.13153016
Zhang, J., Wang, Z., Zhao, R., An, L., Zhou, X., Zhao, Y., & Wang, H. (2020) · Figshare · doi:10.6084/m9.figshare.13153004
Zhang, J., Wang, Z., Zhao, R., An, L., Zhou, X., Zhao, Y., & Wang, H. (2020) · Figshare · doi:10.6084/m9.figshare.13153010
Unraveling the biological functions of UCEC: Insights from a prognostic signature model
Zhu, Q., Shan, W., Li, X., Chen, Y., Huang, X., Xia, B., & Qian, L. (2024) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2024.108219
New lines of research in endometrial cancer
Ginesta, M. ª. P. B., Carbó, A., & Molina, J. P. (2024) · Revisiones en cáncer · doi:10.20960/revcancer.00094
Wang, L., Zhao, Z.-M., & Ma, M.-Y. (2024) · International Conference on Bioinformatics and Biomedical Technology (ICBBT) · doi:10.1145/3674658.3674685
Serous Carcinoma of Uterine Cervix: A Clinicopathological Dilemma
Sarma, R. S., Premalatha, T. S., Kulkarni, K. A., Acharya, G., Bidkar, V. C., & Ravikumar, G. (2024) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-024-00936-4
Yu, J., Guo, K., Xia, M., & Ma, X. (2024) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2024.11.065
Misiek, M., Witczak, G., Picheta, A., Skuza, M., Misiek, A., Kluz, T., Wróbel, A., & Chudecka-Glaz, A. M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020566
Comprehensive analysis of ceRNA Networks in UCEC: Prognostic and therapeutic implications
Fan, L., Lan, M., Wei, X., Wei, L. S., Yang, L., Nong, L., Wei, J., Li, J., & Huang, W. (2025) · PLoS ONE · doi:10.1371/journal.pone.0314314
Urick, M. E., Chalapareddy, S. K., Yu, E., & Bell, D. W. (2025) · Cancer Medicine · doi:10.1002/cam4.70765
Self-citationNuclear circGUSBP1 promotes cancer stemness via transcriptional coordination with OCT4
Lee, Y., Lin, Y., Wu, Y.-S., Tsao, Y.-Y., Lin, Y.-C., Lin, H.-H., Hsu, Y.-F., Wu, Y.-C., Lin, C.-C., Tzeng, H.-E., et al. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123707
Unveiling Residual Diseases of Endometrial Precancer/Cancer After Progestin Therapy
Zheng, W., Fadare, O., & Quick, C. M. (2025) · Springer eBooks · doi:10.1007/978-981-97-4822-8_57
Shah, H., Hossain, F., Islam, M., Sultana, R., Tarique, M. M. A., Alamgir, C. F., Darmini, M., & Banu, J. (2025) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20251982
Imperatorin remits malignant progression of endometrial cancer by silencing E2F1/SLC3A2
Huang, X., Wang, F., Tang, Z., Dong, L., & Wang, X. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2025.100084 · Cited by 1
Sabetian, S., Cava, C., Jahromi, B. N., Askary, E., Alaee, S., & Vakili, B. (2025) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-025-00607-0
Bıldacı, T. B., Ata, C., Atlıhan, U., Avşar, H. A., & Erkılınç, S. (2025) · BMC Cancer · doi:10.1186/s12885-025-14843-0
Dasgupta, S., Das, A., & Bandyopadhyay, U. (2025) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-025-02262-x
Identification of Key Genes Involved in the Occurrence and Development of Endometrial Cancer
Huang, M., Zhu, Q., Tan, K., & Chen, X. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s554568
Xiao, Y., Wang, J., Zhao, X., Xu, J., Zhao, H., Guo, Z., Zhao, J., Zhang, Y., Wang, R., & Zhang, Y. (2025) · Open Life Sciences · doi:10.1515/biol-2025-1172
Chiang, A., Chen, P., & Chu, C.-Y. (2025) · 童綜合醫學雜誌 · doi:10.4103/etmj.etmj-d-25-00026
Zhan, L., Zhang, J., Zhang, J.-H., Liu, X.-J., Guo, B., Chen, J.-H., Tang, Z., Wang, W.-Y., Wang, Q., Wei, B., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22678233
Lin, H.-H., Zeng, W.-H., Yang, H., Huang, L.-S., Pan, R., & Lei, N.-X. (2024) · Figshare · doi:10.6084/m9.figshare.24995493
Xie, S., Jin, Y., Wang, J., Li, J., Peng, M., & Zhu, X. (2024) · Figshare · doi:10.6084/m9.figshare.26688794
Zhan, L., Zhang, J., Zhang, J.-H., Liu, X.-J., Guo, B., Chen, J.-H., Tang, Z.-H., Wang, W.-Y., Wang, Q., Wei, B., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22678230
Xie, S., Jin, Y., Wang, J., Li, J., Peng, M., & Zhu, X. (2024) · Figshare · doi:10.6084/m9.figshare.25341170
Wang, B., Wang, Y., Wang, W., Wang, Z., Zhang, Y., Pan, X., Wen, X., Leng, H., Guo, J., & Ma, X. (2024) · Figshare · doi:10.6084/m9.figshare.26360911
Pang, Y., Bai, G., Zhao, J., Wei, X., Li, R., Li, J., Hu, S., Peng, L., Liu, P., & 毛鸿鸾 (2022) · Figshare · doi:10.6084/m9.figshare.20400973
Wang, B., Wang, Y., Wang, W., Wang, Z., Zhang, Y., Pan, X., Wen, X., Leng, H., Guo, J., & Ma, X. (2024) · Figshare · doi:10.6084/m9.figshare.26361029
Xie, S., Jin, Y., Wang, J., Li, J., Peng, M., & Zhu, X. (2024) · Figshare · doi:10.6084/m9.figshare.26688791
Zhang, J., Wang, Z., Zhao, R., An, L., Zhou, X., Zhao, Y., & Wang, H. (2020) · Figshare · doi:10.6084/m9.figshare.13153022
Xie, S., Jin, Y., Wang, J., Li, J., Peng, M., & Zhu, X. (2024) · Figshare · doi:10.6084/m9.figshare.26688797
Xie, S., Jin, Y., Wang, J., Li, J., Peng, M., & Zhu, X. (2024) · Figshare · doi:10.6084/m9.figshare.25341434
Zhang, J., Wang, Z., Zhao, R., An, L., Zhou, X., Zhao, Y., & Wang, H. (2020) · Figshare · doi:10.6084/m9.figshare.13153025
Xie, S., Jin, Y., Wang, J., Li, J., Peng, M., & Zhu, X. (2024) · Figshare · doi:10.6084/m9.figshare.26688788
Additional file 1 of Genomic profile of Chinese patients with endometrial carcinoma
Li, J., Li, X., Quan, C., Li, X., Wan, C., & Wu, X. (2023) · Figshare · doi:10.6084/m9.figshare.24172101
Wang, B., Wang, Y., Wang, W., Wang, Z., Zhang, Y., Pan, X., Wen, X., Leng, H., Guo, J., & Ma, X. (2024) · Figshare · doi:10.6084/m9.figshare.26752663
Molecular Mechanism of Endometrial Carcinogenesis
Takahashi, K., & Yoshihara, K. (2025) · Comprehensive gynecology and obstetrics · doi:10.1007/978-981-95-0946-1_2
Yılmaz, Z. S. (2026) · Archives of Current Medical Research · doi:10.47482/acmr.1831809
Predictive value of IGF2BP2 for endometrial cancer recurrence: a multicenter study
Xiong, J., Jiang, P., Bai, X., Tu, Y., Tian, C., Gong, C., Gong, Y., Hou, L., Zhao, L., & Yuan, R. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1733447
Chen, X., Liu, S., Luo, D., lin, D., Liu, J., Zhan, H., Chen, S., Deng, P., & Yu, Z. (2026) · Nature Communications · doi:10.1038/s41467-026-71144-1
Metadata
- Authors
- Urick, M. E., & Bell, D. W.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Bell, Daphne W.
- Venue
- Nature Reviews Cancer
- Published
- 2019-08-06
- Volume
- 19
- Issue
- 9
- Pages
- 510-521
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC7446243
- OpenAlex
- W2965204233
- Cited by
- 405
- References
- 157
- Citations by year
- 2026: 19 · 2025: 57 · 2024: 58 · 2023: 70 · 2022: 101 · 2021: 66 · 2020: 32 · 2019: 2
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99 HG999999)
- National Human Genome Research Institute (Z01HG200338, ZIAHG200379, ZIAHG200338)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Keywords
- endometrial cancer, molecular subtyping, molecular targets, targeted therapy, early detection, risk stratification, endometrioid carcinoma, serous carcinoma, clear cell carcinoma, histological subtypes, prognosis
- MeSH terms
- Animals, Carcinoma, Female, Humans, Immunotherapy, Mutation, Prognosis, Risk, Sarcoma, Biomarkers, Tumor, Endometrial Neoplasms, Risk Assessment, Proteomics, Mice, Translational Research, Biomedical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
